April 22-23, 2019
| Register Here |

Are you a small company interested in applying to participate in the Stanford Drug Discovery Showcase session held on April 23?
Submit an application

View last year's Virtual Access Recap


Attendee Information

| Local Hotels | Directions | Parking |

Advances in research and technology now afford us the unique opportunity to develop and test novel diagnostics and therapeutics. This conference takes advantage of the collective experience and expertise of our speakers in drug discovery. A broad range of policy, research, and venture topics are covered.

Lifetime Achievement Award

John C. Martin, PhD

Chairman of the Board of Directors
Former CEO
Gilead

Introduction by Paul Berg, PhD

Robert W. and Vivian K. Cahill Professor of Cancer Research, Emeritus
Stanford University School of Medicine
Nobel Prize 1980

Participants

Anthony Adamis, MD
Senior Vice President of Development and Innovation
Genentech

Howard Bauchner, MD
Editor-in-Chief
JAMA
 
 

Jeffrey Bluestone, PhD
CEO and President
Parker Institute for Cancer Immunotherapy
 

Robert Califf, MD
Former FDA Commissioner

 

James Doroshow, MD
Deputy Director
NIH/NCI

 

Brian Druker, MD
Jeld-Wen Chair of Leukemia Research
Director, Knight Cancer Institute, OHSU

Victor Dzau, MD
National Academy of Medicine



 

Peter Fitzgerald, MD, PhD
Prof Emer, Medicine and Engineering
Director, Center for CV Innovation, Stanford; Founder, Triventures

Sandra Horning, MD
Executive Vice President
Global Development and Chief Medical Officer
Genentech
 

Allan Jones, PhD
CEO
Allen Institute



 

Crystal Mackall, MD
Director
Stanford Center for Cancer Cell Therapy and Parker Institute for Cancer Immunotherapy
 

Mathai Mammen, MD, PhD
Global Head R&D
Janssen


 

Peter Marks, MD, PhD
Director of CBER
FDA


Maria Millan, MD
President and CEO
CIRM

 

Lloyd Minor, MD
Carl and Elizabeth Naumann Professorship for the Dean, Stanford School of Medicine

Beverly Mitchell, MD
Director Emeritus and Senior Advisor
Stanford Cancer Institute

Woodrow Myers, Jr., MD, MBA
Managing Director
Myers  Ventures, LLC
 

Daniel O’Day, MBA
Chairman and Chief Executive Officer
Gilead
 

Andrew Plump, MD, PhD
CSO and CMO
Takeda

 

John Reed, MD, PhD
Executive Vice President and Global Head of Research and Development, Sanofi
 

Alan Sachs, MD, PhD
CSO
Thermo Fisher


 

Camille Samuels, MBA
Partner
Venrock


 

Randy Schekman, PhD
UC, Berkeley
2013 Nobel Prize


 

Carla Shatz, PhD
Sapp Family Provostial Professor; Prof of Biology & Neurobiology; David Starr Jordan Director, Stanford Bio-X

Ram Shriram
Founder
Sherpalo Ventures

 

Orla Smith, PhD
Editor
Science Translational Medicine

Young Sohn
President and CSO, Samsung Electronics
Chairman of the Board, Harman

Marc Tessier-Lavigne, PhD, FRS, FRSC
President and Bing Presidential Professor
Stanford University

Sandy Weill
Chairman Emeritus and Former CEO
Citigroup
 

George Yancopoulos, MD, PhD
President and CSO
Regeneron Pharmaceuticals, Inc.

Tentative Agenda

Please check back regularly for updates

Day 1 | April 22, 2019

Registration and Continental Breakfast

Introduction and Welcome Address

Joseph Wu, MD, PhD | Director, Stanford Cardiovascular Institute | Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford School of Medicine

Lloyd Minor, MD | Dean, Stanford School of Medicine

David Entwistle, MHSA | President and CEO, Stanford Health Care

Paul King, MHA | President and CEO, Stanford Lucile Packard Children's Hospital

Steven Artandi, MD, PhD | Director, Stanford Cancer Institute | Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry, Stanford School of Medicine

Opening Keynote

Victor Dzau, MD | President, National Academy of Medicine

Q & A Session

 

Session I | Government and Philanthropy

Jim Doroshow, MD | NCI Deputy Director for Clinical and Translational Research, NIH

"Big, Team, Open Science at the Allen Institute" | Allan Jones, PhD | President and CEO, Allen Institute

Sandy Weill | Chairman Emeritus and Former CEO, Citigroup

"CIRM: How California’s Investment is Delivering Something Better than Hope" | Maria Millan, MD | President and CEO, CIRM

Panel Discussion

Networking Lunch and Poster Viewing
 

Session II | Publishing Drug Discoveries

"Pre-Print Servers, Data Sharing, and Drug Trials" | Howard Bauchner, MD | Editor-in-Chief, JAMA

"Breaching Barriers in Translational Research" | Orla Smith, PhD | Managing Editor, Science Translational Medicine, Science (AAAS)

Panel Discussion
 

Session III | Stanford Innovative Medicine

Marc Tessier-Lavigne, PhD, FRS, FRSC | President and Bing Presidential Professor, Stanford University

Lloyd Minor, MD | Dean, Stanford School of Medicine

Coffee Break
 

Session IV | Drug Therapeutics

John Reed, MD, PhD | Executive Vice President and Global Head of Research and Development, Sanofi

"Enabling Precision Medicine: Views from an Industry Perspective" | Alan Sachs, MD, PhD | CSO, Thermo Fisher

"Mission-Oriented R&D: Using Heart, Science & Ingenuity, Create Transformational Medicine to Improve the Health of Humanity" | Mathai Mammen, MD, PhD | Global Head of R&D at Janssen Pharmaceutical Company of J&J

"Takeda’s R&D Transformation: The Rebirth of a 238-Year-Old Healthcare Institution" | Andrew Plump, MD, PhD | CSO and CMO, Takeda

Sandra Horning, MD | Executive Vice President, Global Development and Chief Medical Officer, Genentech

Daniel O'Day, MBA | Chairman and Chief Executive Officer, Gilead

Panel Discussion
 

Presentation of Lifetime Achievement Award

Introduction | Paul Berg, PhD | Robert W. and Vivian K. Cahill Professor of Cancer Research, Emeritus, Stanford University School of Medicine | Nobel Prize 1980
 

Awardee Lecture

John Martin, PhD | Former Chairman of the Board, Gilead

 

Reception/Dinner

Hosted by Lloyd Minor, MD | Dean of Stanford University School of Medicine

Day 2 | April 23, 2019

Registration and Continental Breakfast
 

Keynote Address

"How Exosomes are Made and Selectively Capture Small RNAs for Secretion from Human Cells" | Randy Schekman, PhD | HHMI Investigator and Professor, UC Berkley | Nobel Prize 2013

Q&A Session

"Accelerating Progress in Translational Cancer Research Through Data Integration" | Brian Druker, MD | Jeld-Wen Chair of Leukemia Research and Director, Knight Cancer Institute, Oregon Health Science University

Q&A Session
 

Session VI | Immunotherapy

George Yancopoulos, MD, PhD | President and CSO, Regeneron Pharmaceuticals, Inc.

"Exploring Immunotherapy in Immune Diseases and Beyond" | Jeffrey Bluestone, PhD | CEO and President, Parker Institute for Cancer Immunotherapy

"Engineering T Cells for Cancer Therapy" | Crystal Mackall, MD | Professor of Pediatrics and of Medicine, Stanford University

Panel Discussion
 

Stanford Drug Discovery Showcase

Stanford Drug Discovery Showcase featuring: Anthony Adamis, MD; Ram Shriram; Camille Samuels, MBA; Woodrow Myers, MD, MBA  | Small company presentations

Networking Lunch and Poster Viewing
 

Session VII | Artificial Intelligence and Digital Health

Keynote Address

Young Sohn | President and CSO, Samsung Electronics; Chairman of the Board, Harman

Q&A Session

Peter Fitzgerald, MD, PhD | Professor Emeritus, Medicine (Cardiovascular), Stanford University

Coffee Break

Session VIII | Keynote Address

"Advancing the Development of Advanced Therapy Medicinal Products" | Peter Marks, MD, PhD | Director, Center for Biologics Evaluation and Research, U.S. FDA

"Mismatch between Need and Investment in Chronic Disease Drug Development" | Robert Califf, MD | Former FDA Commissioner; Professor of Cardiology, Duke University

Panel Discussion

Closing Remarks, Poster Prize Announcement

Wine and Cheese Reception

Organizers

Joseph C. Wu, MD, PhD

Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine (Cardiology) and Radiology
Stanford University School of Medicine
 

Kuldev Singh, MD

Professor of Ophthalmology
Stanford University School of Medicine



 

Sanjay Malhotra, PhD, FRSC

Associate Professor (Research) of Radiation Oncology (Radiation and Cancer Biology) and Radiology (MIPS)
Stanford University School of Medicine

Mark Mercola, PhD

Professor of Medicine (Cardiovascular)
Stanford University School of Medicine



 

Amanda Chase, PhD

Grant Writer and Project Coordinator
Stanford Cardiovascular Institute



 

Supported by